We are live on
!
Find out more
Xeris Biopharma Holdings
XERS
XERS
237 hedge funds and large institutions have $611M invested in Xeris Biopharma Holdings in 2026 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 99 increasing their positions, 55 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
80% more repeat investments, than reductions
Existing positions increased: 99 | Existing positions reduced: 55
54% more call options, than puts
Call options by funds: $5.19M | Put options by funds: $3.37M
45% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 33
5% more funds holding
Funds holding: 225 → 237 (+12)
0.25% more ownership
Funds ownership: 60.76% → 61.01% (+0.25%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
23% less capital invested
Capital invested by funds: $791M → $611M (-$180M)
Holders
237
Holders Change
+12
Holders Change %
+5.33%
% of All Funds
2.92%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
48
Increased
99
Reduced
55
Closed
33
Calls
$5.19M
Puts
$3.37M
Net Calls
+$1.81M
Net Calls Change
-$2.54M
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$12.7M |
| 2 |
Millennium Management
New York
|
+$9.33M |
| 3 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$7.43M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6.93M |
| 5 |
VC
Voss Capital
Houston,
Texas
|
+$6.73M |
